Form 8-K - Current report:
SEC Accession No. 0000950170-22-009718
Filing Date
2022-05-12
Accepted
2022-05-12 16:33:43
Documents
45
Period of Report
2022-05-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dawn-20220512.htm   iXBRL 8-K 62985
2 EX-99.1 dawn-ex99_1.htm EX-99.1 131071
3 EX-99.2 dawn-ex99_2.htm EX-99.2 35578
4 GRAPHIC img109617361_0.jpg GRAPHIC 20511
5 GRAPHIC dawn-ex99_2s1.jpg GRAPHIC 60762
6 GRAPHIC dawn-ex99_2s2.jpg GRAPHIC 110918
7 GRAPHIC dawn-ex99_2s3.jpg GRAPHIC 71750
8 GRAPHIC dawn-ex99_2s4.jpg GRAPHIC 58037
9 GRAPHIC dawn-ex99_2s5.jpg GRAPHIC 64788
10 GRAPHIC dawn-ex99_2s6.jpg GRAPHIC 56268
11 GRAPHIC dawn-ex99_2s7.jpg GRAPHIC 30157
12 GRAPHIC dawn-ex99_2s8.jpg GRAPHIC 88449
13 GRAPHIC dawn-ex99_2s9.jpg GRAPHIC 75552
14 GRAPHIC dawn-ex99_2s10.jpg GRAPHIC 89207
15 GRAPHIC dawn-ex99_2s11.jpg GRAPHIC 50957
16 GRAPHIC dawn-ex99_2s12.jpg GRAPHIC 63742
17 GRAPHIC dawn-ex99_2s13.jpg GRAPHIC 77613
18 GRAPHIC dawn-ex99_2s14.jpg GRAPHIC 57096
19 GRAPHIC dawn-ex99_2s15.jpg GRAPHIC 82542
20 GRAPHIC dawn-ex99_2s16.jpg GRAPHIC 53408
21 GRAPHIC dawn-ex99_2s17.jpg GRAPHIC 59097
22 GRAPHIC dawn-ex99_2s18.jpg GRAPHIC 77227
23 GRAPHIC dawn-ex99_2s19.jpg GRAPHIC 75426
24 GRAPHIC dawn-ex99_2s20.jpg GRAPHIC 87496
25 GRAPHIC dawn-ex99_2s21.jpg GRAPHIC 60949
26 GRAPHIC dawn-ex99_2s22.jpg GRAPHIC 55336
27 GRAPHIC dawn-ex99_2s23.jpg GRAPHIC 28364
28 GRAPHIC dawn-ex99_2s24.jpg GRAPHIC 81418
29 GRAPHIC dawn-ex99_2s25.jpg GRAPHIC 83743
30 GRAPHIC dawn-ex99_2s26.jpg GRAPHIC 69234
31 GRAPHIC dawn-ex99_2s27.jpg GRAPHIC 26790
32 GRAPHIC dawn-ex99_2s28.jpg GRAPHIC 51741
33 GRAPHIC dawn-ex99_2s29.jpg GRAPHIC 61992
34 GRAPHIC dawn-ex99_2s30.jpg GRAPHIC 51406
  Complete submission text file 0000950170-22-009718.txt   3111087

Data Files

Seq Description Document Type Size
35 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dawn-20220512_lab.xml EX-101.LAB 14010
36 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dawn-20220512.xsd EX-101.SCH 2490
37 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dawn-20220512_pre.xml EX-101.PRE 10289
39 EXTRACTED XBRL INSTANCE DOCUMENT dawn-20220512_htm.xml XML 4955
Mailing Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930
Business Address 395 OYSTER POINT BLVD STE 217 SOUTH SAN FRANCISCO CA 94080-1930 206-913-4300
Day One Biopharmaceuticals, Inc. (Filer) CIK: 0001845337 (see all company filings)

EIN.: 832415215 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40431 | Film No.: 22918420
SIC: 2834 Pharmaceutical Preparations